Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma

被引：0
|
作者：
Guo, S-S. [1 ]
Chen, Q. Y. [1 ]
Liu, L. [1 ]
Sun, R. [1 ]
Wang, P. [1 ]
Li, D. [2 ]
机构：
[1] Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Nasopharyngeal Carcinoma, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.467
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
359MO
引用
收藏
页码：S1609 / S1609
页数：1
相关论文
共 50 条
  • [41] Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma
    Kimmie Ng
    Andrew Hendifar
    Alexander Starodub
    Jorge Chaves
    Yingsi Yang
    Brian Koh
    David Barbie
    William C. Hahn
    Charles S. Fuchs
    Investigational New Drugs, 2019, 37 : 159 - 165
  • [42] A Phase II study of docetaxel, cisplatin, and 5 FU induction chemotherapy followed by chemoradiotherapy in advanced nasopharyngeal cancer
    Bae, W.
    Cho, S.
    Hwang, J.
    Shim, H.
    Lee, J.
    Lim, S.
    Chung, W.
    Chung, I.
    EJC SUPPLEMENTS, 2009, 7 (02): : 488 - 489
  • [43] Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study
    Yu, Nuo
    Chen, Xiankai
    Li, Jiao
    Kang, Xiaozheng
    Wang, Zhen
    Zhang, Ruixiang
    Qin, Jianjun
    Li, Yong
    Zheng, Qingfeng
    Feng, Guojie
    Deng, Lei
    Zhang, Tao
    Wang, Wenqing
    Liu, Wenyang
    Wang, Jianyang
    Feng, Qinfu
    Lv, Jima
    Zhou, Zongmei
    Xiao, Zefen
    Bi, Nan
    Li, Yin
    Wang, Xin
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (12) : 1038 - 1046
  • [44] Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer
    Divers, SG
    Spencer, SA
    Carey, D
    Busby, EM
    Hyatt, MD
    Robert, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6664 - 6673
  • [45] Phase I / II Study of Carboplatin, Nab-Paclitaxel, and Concurrent Radiotherapy for Patients with Locally Advanced NSCLC
    Kawano, Y.
    Sasaki, T.
    Yamaguchi, H.
    Hirano, K.
    Nishio, M.
    Satouchi, M.
    Hosokawa, S.
    Morinaga, R.
    Komiya, K.
    Inoue, K.
    Fujita, Y.
    Toyozawa, R.
    Kimura, T.
    Takahashi, K.
    Nishikawa, K.
    Kishimoto, J.
    Nakanishi, Y.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S635 - S635
  • [46] A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin
    Xu, Zhiyuan
    Yang, Li
    Ng, Wai-Tong
    El Helali, Aya
    Lee, Victor Ho-Fun
    Ma, Lingyu
    Liu, Qin
    Li, Jishi
    Shen, Lin
    Huang, Jijie
    Zha, Jiandong
    Zhou, Cheng
    Lee, Anne W. M.
    Chen, Longhua
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma
    Yau, Tsz-Kok
    Lee, Anne Wing-Mul
    Wong, Dominique Hiu-Ming
    Yeung, Rebecca Mei-Wan
    Chan, Elian Wing-Kin
    Ng, Wai-Tong
    Tong, Macy
    Soong, Inda Sung
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (10): : 880 - 887
  • [48] Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patientsaEuro
    Nakahara, Susumu
    Hanamoto, Atsushi
    Seo, Yuji
    Miyaguchi, Shinichi
    Yamamoto, Yoshifumi
    Tomiyama, Yoichiro
    Yoshii, Tadashi
    Takenaka, Yukinori
    Yoshioka, Yasuo
    Isohashi, Fumiaki
    Ogawa, Kazuhiko
    Inohara, Hidenori
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (10) : 903 - 910
  • [49] Induction Chemotherapy with Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy in Patients with Inoperable Non-nasopharyngeal Carcinoma of the Head and Neck
    Fountzilas, George
    Bamias, Aristotelis
    Kalogera-Fountzila, Anna
    Karayannopoulou, Georgia
    Bobos, Mattheos
    Athanassiou, Eleni
    Kalogeras, Konstantine T.
    Tolis, Christos
    Tsekeris, Periklis
    Papakostas, Pavlos
    Vamvouka, Chrysanthi
    Zaramboukas, Thomas
    Kosmidis, Paris
    Zamboglou, Nikolaos
    Misailidou, Despina
    ANTICANCER RESEARCH, 2009, 29 (02) : 529 - 538
  • [50] A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma.
    Yamouni, M.
    Beldjilali, Y.
    Benhadji, K. A.
    Khellafi, H.
    Betkaoui, F.
    Kaid, Y.
    Benchlef, L.
    Daim, F. Z.
    Toubal, S.
    Boukerche, A.
    Abdelaoui, A.
    Djellali, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345